Skip to Content

WCLC2020: COVID-19 outcomes in patients with thoracic malignancies

Umit Tapan, MD and Assistant Professor of Medicine at Boston University, presents the results from TERAVOLT, a multi-center, international observational study, that include the presence of any thoracic cancer and a COVID-19 diagnosis. Similar to the general population, the mortality rate of males with thoracic cancer is higher than females.

Avaa artikkeli

Jos olet lääkäri, sairaanhoitaja tai muu terveydenhuollon ammattilainen, voit käyttää koko artikkelia luomalla profiilin BestPractice Nordic -sivustolle.

Back to top